Severe asthma: anti-IgE or anti-IL-5?

Eur Clin Respir J · 2016 · PMC5102127 · PMID 27834175

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The study by Flood-Page and colleagues ( 57 ) showed a trend towards reducing severe asthma exacerbations with the higher dose of mepolizumab.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.